Introduction
Obesity, a common nutritional disorder, is the burning Global problem. It is raising concern because of its potential impact on health. It reflects multigenic predisposition to store excess of calories as fat in adipocytes in conjunction with excess of food intake and low physical activity.Increase in weight is strongly associated with dyslipedemia and hyper Leptinemia. Lipid Triad is-increase in Triglycerides (Tgl), increase in Total Cholesterol (TC) and decrease in High Density Lipoprotein (HDL). Lipid Triad was usually found in obese people. It is a strong predictor of endothelial dysfunction and cardio vascular diseases [1] [2] [3] .
Various studies in diverse and ethnic groups have shown strong association between obesity and Lipid Triad 4, 5 . There are strong links between Obesity, Thrombosis, Vascular changes and Atherosclerosis 1 . APO A, the protein fraction of lipoproteins exists on the surface of HDL, known to activate LCAT .It plays an important role in HDL solubilization. APO B is a major structural protein of Chylomicron, VLDL and LDL.
It is a strong factor for atherogenisis. Plasma Lipid and apolipoprotein ratio that include both an atherogenic and an atherogenic protective lipid component like Tgl /HDL, TC/HDL, LDL/HDL, APOB/APO A has been found to be strongly associated with obesity and predictors of Coronary heart disease 6 .
The optimum TC/HDL ratio is 3. If the ratio is more than 5; it appears to be a predictor of CVD 7 . Increased ratio is observed in 25% of Industrial and 32% of urban female population in India 8 . One unit raise in TC/HDL and LDL/HDL ratio is associated with 49% and 75% increased risk of MI respectively 9 . If LDL/HDL ratio is more than 2.5 it is deleterious. The most reliable index is the ratio of APO B/APO A (0.2-0.5). The ratio of 0.4 is very good. The ratio of more than one shows the highest risk. Lp (a) con- Original Article tains a unique protein (apo a), highly glycosylated and structurally different from other apoprotiens. Its lipid composition and structure is similar to that of LDL. It is linked to APO B through a simple disulphide bond. It has many properties in common with LDL including in its clearance rates. Lp (a) synthesized in liver is normally present in low concentration in plasma. Raised Lp (a) more than 30 mg/dl is seen in obese subjects and in patients with coronary heart diseases (CHD), serves in stratifying patients with increased risk of CVD 10, 11 . Lp (a) inhibits fibronolysis. Increased Lp (a) associated with increased LDL, raises the risk of CVD by six times. Hyperlipidemia promotes functional abnormalities and structural vascular wall injury.
Dyslipidemia, C-Reactive Protein and Leptin levels in Non Diabetic Obese subjects
CRP is a normal alpha globulin, which increases in inflammatory process. Higher CRP levels indicates a low-grade systemic inflammation 11, 12 CRP levels are elevated in response to inflammation, acute infections and M.I. Systemic inflammation is associated with increased serum Leptin concentration 13 . It is becoming clear that adipocytes is not merely an inert organ for storage of energy but it also secretes a host of factors that interact with each other to have an effect on various metabolic activities.
Leptin is a protein with 167 amino acids, a member of cytokine family coded by ob gene 14 primarily secreted by adipocytes directly proportional to adipocytes mass and BMI 15 . Its levels are rich in hypothalamus 16 known to regulate body weight. It plays important role in appetite metabolism and energy balance 17, 18 . Leptin is known to stimulate the sympathetic nervous system for a peripheral signal linking adiposity and central neural networks 19 by receptor signal through Tyrosine kinase leading to phosphorylation of members of signal transducer pathway and activator of Transcription protein.
One set of oroxogenic neurons produce appetite stimulating neurotransmitter (NPY), second set of anorexogenic neurons produce appetite suppressing neuropeptide (∝MSH) 20 .
Leptin is known to reduce the expression of NPY and stimulates the expression of ∝MSH, suppressing the anabolic pathway and/ or activating catabolic pathway 16 Leptin has effect on he key organs of metabolism including brain, liver, fat and pancreas 21 . It regulates neuroendocrine function and its secretion, pulsatile with TSH secretion which potentiall increases thermogenesis, by increasing BMR through T3 and T4 levels leading to weight loss. It has a permissive role in the onset of puberty and ovulation 22 . Hyper Leptinemia or Leptin resistance is often associated with dyslipidemia and central obesity 23 . Remarkable linear relationship exists between rise in BMI and Leptin 23 to promote angiogenesis 24 , platelet aggregation 25 ,and Thrombosis 26 .
Experiments on mice by Pellymounter has shown that, Leptin to have anti Diabetic activities 27 , highly efficacious as an anti Diabetic agent and in weight reduction. In Leptin deficient rodents, 1 to 7 kgs of weight reduction was seen in rodents by giving low dose of recombinant Leptin in Leptin deficient Rodents. Hyper Leptinemia prevents lipotropic cardiomyopathy in mice 28 . Rodents and Humans with genetic deficiencies in the Leptin system become morbidly obese supports the importance of Leptin in regulation of energy balance 29 . Leptin deficiency is corrected by the administration of Leptin at doses that raise serum concentration 20-30 times the normal concentration of the animal or human fat mass 28 .
Materials and Methods
The study was carried out in the Department of clinical Biochemistry, Bangalore Medical College. Cases and controls were chosen from the subjects attending the out patient department of Victoria hospital for their routine check up.The protocol of the study was to study and compare the linear relationship of obesity, dyslipidemia, CRP and Leptin levels is Non Diabetic obese persons to Non Diabetic persons with normal weight. The protocol was based on inclusion and exclusion criteria and is approved by local ethical committee.
Control
N=20 age and sex matched healthy individuals with normal weight (BMI 20-25) without clinical evidence of any disease.
Cases
Non-Diabetic obese persons with BMI>30 without clinical evidence of any disease. . They were non alcoholic and non smokers.
Exclusion criteria
Subjects with hypertension and elevated blood sugar levels, infection and inflammation were excluded from the study.
Detailed history of subjects regarding their socioeconomic status, dietary habits, family history for metabolic disorders, their physical activity were taken. Most of them had no family history of Diabetic Mellitus and Hypertension. They were on sedentary life style with overeating tendencies.
Venous blood was collected on overnight fasting at morning 9AM. Blood samples were allowed to clot and serum was separated by centrifugation.
Following parameters were estimated in both cases and controls on the same day of blood collection in auto analyzer-ERBA 600 by using standard kits. Baseline evaluation included determination of Blood sugar, urea and creatinine levels to rule out metabolic disease and organ dysfunction. Leptin levels was estimayed by ELISA method. Serum samples were stored at -20 0 C for estimation of Leptin and CRP levels. The samples were thawed on one stretch for the estimation. Leptin was analyzed by DRG Leptin sand witch ELISA method by using kit from DRG Company. Standard curve was drawn by using various standards of increase in concentration provided in the kit. Controls were run to ascertain reliability of values.Serum samples were diluted 1:10 and the Leptin levels were found out by using the standard curve.
Study Design
A Case-Control study consisting of 50 Non-diabetic cases subjects (With BMI >30) and 25 non-diabetics with normal weight (BMI 20-25) is undertaken to study the effect of obesity on Lipid parameters, Leptin and CRP.
The Blood sugar levels in Normal and Obese groups are statistically comparable, and are clinically within the Normal group to support the non-diabetic population.
The Total cholesterol (mg/dl) is 184.12 (SD:45.21) and in obese it was 271.66(SD:40.03), the cholesterol level is significantly increased in non-diabetic group with P<0.001** and effect of obesity on total cholesterol is very large (d=2.07). Total cholesterol is also clinically significant apart from statistical significant. 
Discussion
Present study shows association of dyslipidemia, raised CRP and increased Leptin levels in Non Diabetic obese cases (BMI>30) as compared to Non Diabetic normal weight subjects.Obesity has an unusually adverse effect on metabolic profile. Many underlying mechanism in addition to adiposity are likely to play a role in causing dyslipedema and its associated effects on health. The study showed elevated levels of Tgl (p<0.001) with a large effects of d=2.09, Total cholesterol (p<0.001), VLDL(p< 0.006), LDL (p<0.001), APO B (p<0.001). Lp (a) (p<0.001), decreased levels of APO A (p<0.05), HDL (p<0.001). The study shows raised CRP (p<0.05), and Leptin levels (p<0.001) in cases as compare to controls. Similar finding has been reported by Daneesh etal12 showing strong inverse relationship between atherogenic and atherogenic protective factors in linking obesity and dyslipidemia. APO A, the chief protein of HDL is an activator of LCAT, which esterifies cholesterol, thus helps in lowering cholesterol level by reverse transport mechanism. It has an important role in regulating LDL metabolism and in APO (B) degradation.
APO B is the apoprotein of LDL. Triglyceride is the major component of LDL and VLDL. Decrease in atherogenic protective factor-APO A and HDL accounts for the increased LDL ,VLDL, Tgl and Cholesterol levels asserting the role of HDL as good Cholesterol in clearing cholesterol level and in lowering LDL fraction. Predominance of small dense LDL significantly increases Triglyceride concentration.
There is significant increase in Lp(a ) (p<0001 )in cases as compared to controls . Lp(a) has cholesterol rich cores similar to LDL. It could promote cholesterol delivery in to the artery wall known to stimulate smooth muscle proliferation. Increase in CRP (p<0.05) concentration in cases as compared to cases indicates a low grade systemic inflammation 12, 30 .
HDL Cholesterol has antioxidant, antithrombotic and antiinflammatory action 31, 32 relationship between decreased HDL, APO A with increased CRP levels indicates the role of CRP in anti inflammatory action 33 . Dyslypidemia with poor physical activity may show anti oxidant activity with proinflammatory state 34 .
The study shows the ratios of atherogenic and atherogenic protective factors. TC /HDL ratio is more than five in obese subjects as compared to controls.LDL/HDL ratio is more than five in cases, Tgl/HDL ratio is 9.7 as compared to 5.3 in controls. APO B/APO A ratio is more than one showing the levels being deleterious .Most obese subjects have high serum leptin levels and presumed to have leptin resistence 35 .
Tgl/HDL ratio suggests a metabolic interaction between Triglyceride and cholesterol rich lipoprotein in increasing the risk of MI. Higher Leptin level in obese subject is in agreement with other studies 15, 20 . Hyper Leptinemia is strongly associated with obesity and dislipidemia substantiating the statement that "Fat talks to brain". Adipocytes are signaling the brain to stimulate the central mechanism to regulate food intake and energy expenditure 36 . Pellymounter 27 indicated Leptin as an anti Diabetic agent and weight reducing substance. Many animal experiments have shown hyper Leptinemia to prevent lipotropic cardiomyopathy 28, 37 . Lipotoxic cardiomyopathy was completely prevented by elevating plasma Leptin levels in mice and rodents 28 .
Conclusion
Present study has shown a strong link between obesity, dislipidemia and cardiovascular disease in accordance with other studies. The role of Leptin associated with cardiovascular disease is not well established, so prospective study should be carried out to elucidate the role of Leptin in cardio vascular disease and Diabetes to establish its role as, whether it is causative, additive risk factor or a protective factor. Leptin may play a role to prevent metabolic syndrome by its interaction with neuroendocrine systems to maintain metabolic homeostasis, similar to the role played by Insulin in homeostasis of blood sugar level. Complete knowledge of intricate mechanism of adipocytes and its metabolic role along with hormonal, neuronal interactions is essential to understand the action of Leptin in weight reduction. It is also crucial to know the Pharmokinetic and Pharmodynamic profile of Leptin, for its utilization as a therapeutic agent in clinical diagnosis and treatment of obesity and its associated disorders.
Epidemiological study and further research has to be carried out to elucidate the ultra molecular mechanisms in underlying the hormonal regulations of Leptin production and its strong link to Endocrine syndrome, which helps to solve the global problem of obesity and its associated disorders. Table 2 . Blood Sugar levels in Normal and Obese subjects 
